Stay updated on Pembrolizumab in HR-Competent & Deficient Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in HR-Competent & Deficient Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in HR-Competent & Deficient Tumors Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.2, replacing Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:27:47.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Minor edits to the Publications section note clarifying that publications are provided voluntarily by the person entering information about the study and pertain to the results. A new Revision: v3.3.1 was added; the previous version was v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-24T12:17:14.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Notice about government funding and NIH Clinical Center operating status was removed from the page. All study details and trial information remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T06:22:22.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Added a Study Results section and a Publications entry (Biomarker Research 2022) for pembrolizumab activity in Fanconi anemia pathway tumors on the Study Details page.
    Difference
    0.5%
    Check dated 2025-11-03T00:59:42.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Summary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.
    Difference
    4%
    Check dated 2025-10-05T09:18:43.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive changes.
    Difference
    0.1%
    Check dated 2025-09-28T03:07:26.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in HR-Competent & Deficient Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in HR-Competent & Deficient Tumors Clinical Trial page.